On 14 November 2025, Beijing Airdoc Technology Co., Ltd. disclosed a repurchase of 19,500 H shares on The Stock Exchange of Hong Kong at prices ranging from HKD 11.91 to HKD 11.98. This amounted to approximately 0.019% of the company’s 103,011,513 issued H shares (excluding treasury shares) prior to the transaction.

Following this repurchase, the total number of issued shares (excluding treasury shares) is 102,992,013, while the number of treasury shares has increased to 576,000. The overall tally of issued shares, including treasury shares, remains at 103,568,013.

Under the repurchase mandate approved on 27 June 2025, the company is authorized to repurchase up to 10,315,601 shares. So far, 164,000 H shares (about 0.159% of the total issued shares as of the mandate date) have been repurchased under this authorization. A 30-day moratorium applies to new share issuances or sales of treasury shares, extending until 14 December 2025.